Patient variable | Outcome | ||
---|---|---|---|
Gender, n (%) | Female/Male | 240 (61)/153 (39) | |
Age yrs., n (%) | ≤30 | 9 (2.3) | |
31–45 | 22 (5.6) | ||
46–59 | 81 (20.6) | ||
60–75 | 154 (39.2) | ||
76–85 | 99 (25.2) | ||
≥86 | 28 (3.1) | ||
Education, n (%) | Lower | 143 (36.3) | |
Middle | 83 (21.1) | ||
Higher | 46 (11.7) | ||
Othera | 121 (31) | ||
Recurrence of the complaint, n (%) | Yes | 139 (36) | |
No | 250 (64) | ||
Severity, mean (SD, 95 % C.I.) | Start therapy | 6.84 (0.1, 6.6–7.0) | |
End therapy | 3.19 (0.1, 2.9–3.4) | ||
Disease, n | Cancer | Neoplasm or lymphatic system | 1 |
Esophageal malignancy | 1 | ||
Nervous system | 1 | ||
Neoplasm bronchus/lung | 1 | ||
Cardiovascular | Heart failure | 2 | |
Heart valve disease | 2 | ||
Cerebral ischemia | 1 | ||
Cerebrovascular accident | 39 | ||
Claudicatio intermittent | 18 | ||
Rheumatic disorders | Fibromyalgia | 15 | |
Rheumatoid arthritisb | 40 | ||
Other arthritis | 26 | ||
Tietze syndrome | 4 | ||
Degenerative bone and joint disorders | Osteoarthritis of the Spine | 76 | |
Osteoarthritis of the Hip | 34 | ||
Osteoarthritis of the Knee | 70 | ||
Osteoporosis | 16 | ||
Disorder (central) nervous system | Multiple sclerosis | 6 | |
Parkinson | 15 | ||
Alzheimer disease | 2 | ||
Lung diseases | Chronic bronchitis | 2 | |
Emphysema/COPD | 17 | ||
Asthma | 2 | ||
Metabolic disorders | Cystic fibrosis | 1 | |
Diabetes Mellitus | 1 |